[
    [
        {
            "time": "",
            "original_text": "东吴证券维持天坛生物买入评级，2020年报及2021年一季报点评：业绩符合预期，血制品业务持续增长",
            "features": {
                "keywords": [
                    "天坛生物",
                    "买入评级",
                    "2020年报",
                    "2021一季报",
                    "血制品业务",
                    "业绩增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "东吴证券维持天坛生物买入评级，2020年报及2021年一季报点评：业绩符合预期，血制品业务持续增长",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "真心看好：“千亿顶流”连续四个季度大手笔加仓这个赛道",
            "features": {
                "keywords": [
                    "千亿顶流",
                    "加仓",
                    "赛道"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "未明确"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "真心看好：“千亿顶流”连续四个季度大手笔加仓这个赛道",
                "Correlation": 5,
                "Sentiment": 9,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "天坛生物（600161）：疫情影响基本消退 采浆量和吨浆效率仍具成长空间",
            "features": {
                "keywords": [
                    "天坛生物",
                    "疫情影响",
                    "采浆量",
                    "吨浆效率",
                    "成长空间"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "天坛生物（600161）：疫情影响基本消退 采浆量和吨浆效率仍具成长空间",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "国元证券：天坛生物（600161.SH）定增落地助力新产能+新产品，维持“增持”评级",
            "features": {
                "keywords": [
                    "国元证券",
                    "天坛生物",
                    "定增落地",
                    "新产能",
                    "新产品",
                    "增持评级"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "国元证券：天坛生物（600161.SH）定增落地助力新产能+新产品，维持“增持”评级",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "国元证券给予天坛生物增持评级，天坛生物2020年报&2021年一季报点评：业绩恢复高增长，定增落地助力新产能+新产品",
            "features": {
                "keywords": [
                    "国元证券",
                    "天坛生物",
                    "增持评级",
                    "2020年报",
                    "2021一季报",
                    "业绩高增长",
                    "定增落地",
                    "新产能",
                    "新产品"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国元证券给予天坛生物增持评级，天坛生物2020年报&2021年一季报点评：业绩恢复高增长，定增落地助力新产能+新产品",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "每日“药”闻|百济神州2020年亏损15.97亿美金；长效RSV抗体三期临床成功",
            "features": {
                "keywords": [
                    "百济神州",
                    "亏损",
                    "RSV抗体",
                    "三期临床成功"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "每日“药”闻|百济神州2020年亏损15.97亿美金；长效RSV抗体三期临床成功",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "艾尔建又有医美新品；参天全球最大生产基地开工；天坛生物非公开发行A股",
            "features": {
                "keywords": [
                    "艾尔建",
                    "医美新品",
                    "参天",
                    "生产基地",
                    "天坛生物",
                    "非公开发行A股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "艾尔建又有医美新品；参天全球最大生产基地开工；天坛生物非公开发行A股",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]